1. Using Bioluminescence Resonance Energy Transfer (BRET) to Characterize Agonist-Induced Arrestin Recruitment to Modified and Unmodified G Protein-Coupled Receptors. Donthamsetti P, Quejada JR, Javitch JA, Gurevich VV, Lambert NA (2015) Curr Protoc Pharmacol : 2.14.1-14
    › Primary publication · 26331887 (PubMed) · PMC4583203 (PubMed Central)
  2. The rhodopsin-arrestin-1 interaction in bicelles. Chen Q, Vishnivetskiy SA, Zhuang T, Cho MK, Thaker TM, Sanders CR, Gurevich VV, Iverson TM (2015) Methods Mol Biol : 77-95
    › Primary publication · 25697518 (PubMed) · PMC4520306 (PubMed Central)
  3. Quantitative Signaling and Structure-Activity Analyses Demonstrate Functional Selectivity at the Nociceptin/Orphanin FQ Opioid Receptor. Chang SD, Mascarella SW, Spangler SM, Gurevich VV, Navarro HA, Carroll FI, Bruchas MR (2015) Mol Pharmacol 88(3): 502-11
    › Primary publication · 26134494 (PubMed) · PMC4551045 (PubMed Central)
  4. Influence of Arrestin on the Photodecay of Bovine Rhodopsin. Chatterjee D, Eckert CE, Slavov C, Saxena K, F├╝rtig B, Sanders CR, Gurevich VV, Wachtveitl J, Schwalbe H (2015) Angew Chem Int Ed Engl 54(46): 13555-60
    › Primary publication · 26383645 (PubMed) · PMC4685475 (PubMed Central)
  5. How genetic errors in GPCRs affect their function: Possible therapeutic strategies. Stoy H, Gurevich VV (2015) Genes Dis 2(2): 108-132
    › Primary publication · 26229975 (PubMed) · PMC4516391 (PubMed Central)
  6. GRK3 suppresses L-DOPA-induced dyskinesia in the rat model of Parkinson's disease via its RGS homology domain. Ahmed MR, Bychkov E, Li L, Gurevich VV, Gurevich EV (2015) Sci Rep : 10920
    › Primary publication · 26043205 (PubMed) · PMC4455246 (PubMed Central)
  7. G Protein-coupled Receptor Kinases of the GRK4 Protein Subfamily Phosphorylate Inactive G Protein-coupled Receptors (GPCRs). Li L, Homan KT, Vishnivetskiy SA, Manglik A, Tesmer JJ, Gurevich VV, Gurevich EV (2015) J Biol Chem 290(17): 10775-90
    › Primary publication · 25770216 (PubMed) · PMC4409243 (PubMed Central)
  8. G Protein-Coupled Receptor Kinase 2 (GRK2) and 5 (GRK5) Exhibit Selective Phosphorylation of the Neurotensin Receptor in Vitro. Inagaki S, Ghirlando R, Vishnivetskiy SA, Homan KT, White JF, Tesmer JJ, Gurevich VV, Grisshammer R (2015) Biochemistry 54(28): 4320-9
    › Primary publication · 26120872 (PubMed) · PMC4512254 (PubMed Central)
  9. GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014. Heifetz A, Schertler GF, Seifert R, Tate CG, Sexton PM, Gurevich VV, Fourmy D, Cherezov V, Marshall FH, Storer RI, Moraes I, Tikhonova IG, Tautermann CS, Hunt P, Ceska T, Hodgson S, Bodkin MJ, Singh S, Law RJ, Biggin PC (2015) Naunyn Schmiedebergs Arch Pharmacol 388(8): 883-903
    › Primary publication · 25772061 (PubMed) · PMC4495723 (PubMed Central)
  10. Development of an MRI biomarker sensitive to tetrameric visual arrestin 1 and its reduction via light-evoked translocation in vivo. Berkowitz BA, Gorgis J, Patel A, Baameur F, Gurevich VV, Craft CM, Kefalov VJ, Roberts R (2015) FASEB J 29(2): 554-64
    › Primary publication · 25351983 (PubMed) · PMC4314227 (PubMed Central)